Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
How embodied is action language? Neurological evidence from motor diseases.
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients.
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Proton detection for signal enhancement in solid-state NMR experiments on mobile species in membrane proteins.
JAML mediates monocyte and CD8 T cell migration across the brain endothelium.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Therapeutic Effect of Transplanted Human Wharton's Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
PET in Multiple Sclerosis.
Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease.
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.
Multiple sclerosis.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Pages
« first
‹ previous
…
509
510
511
512
513
514
515
516
517
…
next ›
last »